Physician profile
Dante A Implicito
NPI 1578586632
$17,622.94
in general payments reported to CMS, 2019-2025
6 companies · $69.84 in 2025
The $69.84 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $7,673 · 2021: $4,947 · 2022: $4,101 · 2023: $616 · 2024: $44.78 · 2025: $69.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $616 · Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $616.47 |
| Food and Beverage | $114.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altus Partners. LLC | $15,594.30 | 2020-2023 | Valencia Pedicle Screw System |
| Globus Medical, INC. | $1,899.67 | 2019-2022 | |
| Alphatec Spine, INC | $50.50 | 2025 | Invictus Mis |
| 4web, INC. | $44.78 | 2024 | Spine Truss System |
| Dynasplint Systems INC. | $19.34 | 2025 | Dynasplint |
| Pacira Pharmaceuticals Incorporated | $14.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dante Implicito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.